 |
|
|
|
|
I. Challenges Faced by the Pharmaceutical Industry |
|
|
|
| |
|
|
|
|
|
II. Responses to the Challenges |
|
|
|
| |
|
|
|
|
|
III. Enter the Clinical Research Organization (CRO) |
|
|
|
| |
|
|
|
|
|
A. CRO Definition |
|
|
|
| |
|
|
|
|
|
B. CRO Origins |
|
|
|
| |
|
|
|
|
|
C. Multinational Expansion |
|
|
|
| |
|
|
|
|
|
D. Rationale for Using CROs |
|
|
|
| |
|
|
|
|
|
E. Preferred Supplier Relationships |
|
|
|
| |
|
|
|
|
|
F. Keys to Success |
|
|
|
| |
|
|
|
|
|
IV. Project Implementation |
|
|
|
| |
|
|
|
|
|
A. Data Retrieval and Review |
|
|
|
| |
|
|
|
|
|
B. Capture and Transfer of Data Generated Outside the Clinic |
|
|
|
| |
|
|
|
|
|
C. Access to Data |
|
|
|
| |
|
|
|
|
|
D. International Databases: Integration of Data |
|
|
|
| |
|
|
|
|
|
E. Support for Regulatory Filings and Marketing Efforts |
|
|
|
| |
|
|
|
|
|
V. Concluding Observation |
|
|
|
| |
|
|
|
|
|
References |
|
|
|
| |